Evidence map›Paper›PMID 19389850›Full record

ArticleJournal of the American Society of Nephrology : JASN2009

HNF1B mutations associate with hypomagnesemia and renal magnesium wasting.

Shazia Adalat, Adrian S Woolf, Karen A Johnstone, Andrea Wirsing, Lorna W Harries, David A Long, Raoul C Hennekam, Sarah E Ledermann, Lesley Rees, William van't Hoff and 14 more

Open access · greenAbstract read
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 118 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
118citing papers in PubMed, 1 pooled it
6.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

118 citing papers in PubMed, 1 synthesis or guideline pooled it, 273 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Clinical kidney journal · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. A Case of Diabetes Mellitus Type MODY5 as a Feature of 17q12 Deletion SyndromeJournal of clinical research in pediatric endocrinology · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Pregnancy outcome with maternalObstetric medicine · 2023
    Review

58 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 3 institutions in 1 country.

Shazia AdalatNephrology Unit, Great Ormond Street Hospital NHS Trust, London WCIN 3JH, UK.
Adrian S Woolf
Karen A Johnstone
Andrea Wirsing
Lorna W Harries
David A Long
Raoul C Hennekam
Sarah E Ledermann
Lesley Rees
William van't Hoff
Stephen D Marks
Richard S Trompeter
Kjell Tullus
Paul J Winyard
Janette Cansick
Imran Mushtaq
Harjeeta K Dhillon
Coralie Bingham
Emma L Edghill
Rukshana Shroff
Horia Stanescu
Gerhart U Ryffel
Sian Ellard
Detlef Bockenhauer
University College London · GBGreat Ormond Street Hospital · GBThe Royal Free Hospital · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

Mutations in hepatocyte nuclear factor 1B (HNF1B), which is a transcription factor expressed in tissues including renal epithelia, associate with abnormal renal development. While studying renal phenotypes of children with HNF1B mutations, we identified a teenager who presented with tetany and hypomagnesemia. We retrospectively reviewed radiographic and laboratory data for all patients from a single center who had been screened for an HNF1B mutation. We found heterozygous mutations in 21 (23%) of 91 cases of renal malformation. All mutation carriers had abnormal fetal renal ultrasonography. Plasma magnesium levels were available for 66 patients with chronic kidney disease (stages 1 to 3). Striking, 44% (eight of 18) of mutation carriers had hypomagnesemia (<1.58 mg/dl) compared with 2% (one of 48) of those without mutations (P < 0.0001). The median plasma magnesium was significantly lower among mutation carriers than those without mutations (1.68 versus 2.02 mg/dl; P < 0.0001). Because hypermagnesuria and hypocalciuria accompanied the hypomagnesemia, we analyzed genes associated with hypermagnesuria and detected highly conserved HNF1 recognition sites in FXYD2, a gene that can cause autosomal dominant hypomagnesemia and hypocalciuria when mutated. Using a luciferase reporter assay, we demonstrated HNF1B-mediated transactivation of FXYD2. These results extend the phenotype of HNF1B mutations to include hypomagnesemia. HNF1B regulates transcription of FXYD2, which participates in the tubular handling of Mg(2+), thus describing a role for HNF1B not only in nephrogenesis but also in the maintenance of tubular function.

Indexed as

MutationAdolescentFamilyFemaleGenetic Carrier ScreeningGlomerular Filtration RateHepatocyte Nuclear Factor 1-betaHumansKidneyMagnesiumMagnesium DeficiencyMaleRetrospective StudiesUltrasonographyWasting SyndromeHepatocyte Nuclear Factor 1-betaHNF1B protein, humanMagnesium

Identifiers

PMID19389850
PMCPMC2678044
OpenAlexW2104529068

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.